|
Corporate Social Responsibility
Ethics 21
Use of laboratory animals for research - Policy
- To print this page, please use the File menu or press simultaneously ctrl + p keys.
- Send this page
Beyond strict compliance with the various regulations in effect, the Group's proactive approach is illustrated by the creation of the sanofi-aventis Charter on the Humane Care and Use of Laboratory Animals and by the fact that it obtains accreditation for its programs on the care and use of laboratory animals.
The Group adheres to the 3R Principle (Reduction /Replacement /Refinement) and has taken a series of initiatives in line with this principle. Sanofi-aventis pays particular attention to animal welfare and applies the highest standards of care. It takes every measure to avoid pain and distress for animals. The Group submits all study protocols for approval by an internal ethics committee; the committee validates the scientific value of the experiment, ensures no other validated method can be used and assesses the level of pain experienced by the animal. In addition, sanofi-aventis uses the lowest possible number of animals, encourages the use of alternative methods and ensures that all personnel is qualified and competent. Progress and Goals| Areas for Progress | Goals |
|---|
| Obtain independent accreditation from an international organization with respect to our scientific and ethical standards | Obtain accreditation from A.A.A.L.A.C (Association for Assessment and Accreditation of Laboratory Animal Care) for 16 R&D sites by 2012 and for all 4 sites Sanofi Pasteur by 2011 | | Establish a policy of continuous training for personnel in charge of animal welfare | Train 30% of relevant employees in 2010 thanks to a re-qualification training session |
|
